{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:44:19Z","timestamp":1792788259212,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Research Foundation of Korea (NRF) grant funded by the Korean government","award":["RS-2024-00454715"],"award-info":[{"award-number":["RS-2024-00454715"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the National Research Foundation of Korea (NRF) grant funded by the Korean government","award":["RS-2024-00343239"],"award-info":[{"award-number":["RS-2024-00343239"]}],"id":[{"id":"https:\/\/ror.org\/013aysd81","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Ministry of Environment of Korea","award":["RS-2023-00230402"],"award-info":[{"award-number":["RS-2023-00230402"]}],"id":[{"id":"https:\/\/ror.org\/04xmt0833","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the KBRI basic research program through the Korea Brain Research Institute funded by the Ministry of Science and ICT","award":["26-BR-04-01"],"award-info":[{"award-number":["26-BR-04-01"]}],"id":[{"id":"https:\/\/ror.org\/01wpjm123","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the KBRI basic research program through the Korea Brain Research Institute funded by the Ministry of Science and ICT","award":["26-BR-02-03, 26-BR-02-05, 26-BR-04-01"],"award-info":[{"award-number":["26-BR-02-03, 26-BR-02-05, 26-BR-04-01"]}],"id":[{"id":"https:\/\/ror.org\/01wpjm123","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the KBRI basic research program through the Korea Brain Research Institute funded by the Ministry of Science and ICT","award":["26-BR-02-03, 26-BR-02-05, 26-BR-04-01, 26-BR-06-02"],"award-info":[{"award-number":["26-BR-02-03, 26-BR-02-05, 26-BR-04-01, 26-BR-06-02"]}],"id":[{"id":"https:\/\/ror.org\/01wpjm123","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Korea Technology and Information Promotion Agency for SMEs (TIPA) funded by the Ministry of SMEs and Startups","award":["RS-2024-00512888"],"award-info":[{"award-number":["RS-2024-00512888"]}],"id":[{"id":"https:\/\/ror.org\/022c4zk48","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-026-02377-w","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T09:15:36Z","timestamp":1783674936000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cross-disease LC\u2013MS\/MS plasma proteomics identifies reproducible shared and disease-enriched biomarker signatures in neurodegenerative disorders"],"prefix":"10.1186","volume":"14","author":[{"given":"Youngtae","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinrye","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janbolat","family":"Ashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wookyung","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunji","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Sung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hyuk","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Jun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6777-6725","authenticated-orcid":false,"given":"Mookyung","family":"Cheon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"2377_CR1","doi-asserted-by":"publisher","first-page":"102357","DOI":"10.1016\/j.arr.2024.102357","volume":"99","author":"DG Gadhave","year":"2024","unstructured":"Gadhave DG, Sugandhi VV, Jha SK, Nangare SN, Gupta G, Singh SK, Dua K, Cho H, Hansbro PM, Paudel KR (2024) Neurodegenerative disorders: mechanisms of degeneration and therapeutic approaches with their clinical relevance. Ageing Res Rev 99:102357. https:\/\/doi.org\/10.1016\/j.arr.2024.102357","journal-title":"Ageing Res Rev"},{"key":"2377_CR2","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.14336\/AD.2024.1071","volume":"16","author":"S Wang","year":"2024","unstructured":"Wang S, Jiang Y, Yang A, Meng F, Zhang J (2024) The expanding burden of neurodegenerative diseases: an unmet medical and social need. Aging Dis 16:2937\u20132952. https:\/\/doi.org\/10.14336\/AD.2024.1071","journal-title":"Aging Dis"},{"key":"2377_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/2047-9158-1-5","volume":"1","author":"AJ Stoessl","year":"2012","unstructured":"Stoessl AJ (2012) Neuroimaging in the early diagnosis of neurodegenerative disease. Transl Neurodegener 1:5. https:\/\/doi.org\/10.1186\/2047-9158-1-5","journal-title":"Transl Neurodegener"},{"key":"2377_CR4","doi-asserted-by":"publisher","first-page":"792227","DOI":"10.3389\/fneur.2021.792227","volume":"12","author":"A Schumacher-Schuh","year":"2021","unstructured":"Schumacher-Schuh A, Bieger A, Borelli WV, Portley MK, Awad PS, Bandres-Ciga S (2021) Advances in proteomic and metabolomic profiling of neurodegenerative diseases. Front Neurol 12:792227. https:\/\/doi.org\/10.3389\/fneur.2021.792227","journal-title":"Front Neurol"},{"key":"2377_CR5","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/s43587-022-00300-1","volume":"2","author":"M Del Campo","year":"2022","unstructured":"Del Campo M, Peeters CFW, Johnson ECB, Vermunt L, Hok AHYS, van Nee M, Chen-Plotkin A, Irwin DJ, Hu WT, Lah JJ et al (2022) CSF proteome profiling across the Alzheimer\u2019s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels. Nat Aging 2:1040\u20131053. https:\/\/doi.org\/10.1038\/s43587-022-00300-1","journal-title":"Nat Aging"},{"key":"2377_CR6","doi-asserted-by":"publisher","first-page":"100877","DOI":"10.1016\/j.mcpro.2024.100877","volume":"23","author":"V Albrecht","year":"2024","unstructured":"Albrecht V, Muller-Reif J, Nordmann TM, Mund A, Schweizer L, Geyer PE, Niu L, Wang J, Post F, Oeller M et al (2024) Bridging the gap from proteomics technology to clinical application: highlights from the 68th Benzon Foundation Symposium. Mol Cell Proteomics 23:100877. https:\/\/doi.org\/10.1016\/j.mcpro.2024.100877","journal-title":"Mol Cell Proteomics"},{"key":"2377_CR7","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/s43856-025-01183-0","volume":"5","author":"A Kamalian","year":"2025","unstructured":"Kamalian A, Shichkova P, Tognetti M, Below C, Ho SG, Bruderer R, Reiter L, Feng Y, Lutz MW, Moghekar A (2025) Unveiling proteomic and peptide-level modifications in cerebrospinal fluid and plasma in normal cognitive aging. Commun Med 5:474. https:\/\/doi.org\/10.1038\/s43856-025-01183-0","journal-title":"Commun Med"},{"key":"2377_CR8","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1038\/s43587-025-01006-w","volume":"5","author":"I Caro","year":"2025","unstructured":"Caro I, Western D, Namba S, Sun N, Kawaguchi S, He Y, Fujita M, Roshchupkin G, D\u2019Aoust T, Duperron MG et al (2025) Proteogenomics in cerebrospinal fluid and plasma reveals new biological fingerprint of cerebral small vessel disease. Nat Aging 5:2514\u20132531. https:\/\/doi.org\/10.1038\/s43587-025-01006-w","journal-title":"Nat Aging"},{"key":"2377_CR9","doi-asserted-by":"publisher","first-page":"1426700","DOI":"10.3389\/fnins.2024.1426700","volume":"18","author":"C Park","year":"2024","unstructured":"Park C, Weerakkody JS, Schneider R, Miao S, Pitt D (2024) CNS cell-derived exosome signatures as blood-based biomarkers of neurodegenerative diseases. Front Neurosci 18:1426700. https:\/\/doi.org\/10.3389\/fnins.2024.1426700","journal-title":"Front Neurosci"},{"key":"2377_CR10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1212\/WNL.0000000000207193","volume":"101","author":"D Alcolea","year":"2023","unstructured":"Alcolea D, Beeri MS, Rojas JC, Gardner RC, Lleo A (2023) Blood biomarkers in neurodegenerative diseases: implications for the clinical neurologist. Neurology 101:172\u2013180. https:\/\/doi.org\/10.1212\/WNL.0000000000207193","journal-title":"Neurology"},{"key":"2377_CR11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/arclin\/acae019","volume":"39","author":"HE Dark","year":"2024","unstructured":"Dark HE, Duggan MR, Walker KA (2024) Plasma biomarkers for Alzheimer\u2019s and related dementias: a review and outlook for clinical neuropsychology. Arch Clin Neuropsychol 39:313\u2013324. https:\/\/doi.org\/10.1093\/arclin\/acae019","journal-title":"Arch Clin Neuropsychol"},{"key":"2377_CR12","doi-asserted-by":"publisher","first-page":"8117","DOI":"10.3390\/ijms24098117","volume":"24","author":"H Ehtewish","year":"2023","unstructured":"Ehtewish H, Mesleh A, Ponirakis G, De la Fuente A, Parray A, Bensmail I, Abdesselem H, Ramadan M, Khan S, Chandran M et al (2023) Blood-based proteomic profiling identifies potential biomarker candidates and pathogenic pathways in dementia. Int J Mol Sci 24:8117. https:\/\/doi.org\/10.3390\/ijms24098117","journal-title":"Int J Mol Sci"},{"key":"2377_CR13","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1038\/s41467-021-22767-z","volume":"12","author":"W Zhong","year":"2021","unstructured":"Zhong W, Edfors F, Gummesson A, Bergstrom G, Fagerberg L, Uhlen M (2021) Next generation plasma proteome profiling to monitor health and disease. Nat Commun 12:2493. https:\/\/doi.org\/10.1038\/s41467-021-22767-z","journal-title":"Nat Commun"},{"key":"2377_CR14","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1038\/s41591-025-03834-0","volume":"31","author":"F Imam","year":"2025","unstructured":"Imam F, Saloner R, Vogel JW, Krish V, Abdel-Azim G, Ali M, An L, Anastasi F, Bennett D, Pichet Binette A et al (2025) The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging. Nat Med 31:2556\u20132566. https:\/\/doi.org\/10.1038\/s41591-025-03834-0","journal-title":"Nat Med"},{"key":"2377_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M, Benner C, Hsu YH, Richardson TG, Surendran P, Mahajan A, Robins C, Vasquez-Grinnell SG et al (2023) Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622:329\u2013338. https:\/\/doi.org\/10.1038\/s41586-023-06592-6","journal-title":"Nature"},{"key":"2377_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1023\/a:1014580219761","volume":"17","author":"D Guidetti","year":"2001","unstructured":"Guidetti D, Sabadini R, Ferlini A, Torrente I (2001) Epidemiological survey of X-linked bulbar and spinal muscular atrophy, or Kennedy disease, in the province of Reggio Emilia, Italy. Eur J Epidemiol 17:587\u2013591. https:\/\/doi.org\/10.1023\/a:1014580219761","journal-title":"Eur J Epidemiol"},{"key":"2377_CR17","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1073\/pnas.0809819106","volume":"106","author":"E Suzuki","year":"2009","unstructured":"Suzuki E, Zhao Y, Ito S, Sawatsubashi S, Murata T, Furutani T, Shirode Y, Yamagata K, Tanabe M, Kimura S et al (2009) Aberrant E2F activation by polyglutamine expansion of androgen receptor in SBMA neurotoxicity. Proc Natl Acad Sci USA 106:3818\u20133822. https:\/\/doi.org\/10.1073\/pnas.0809819106","journal-title":"Proc Natl Acad Sci USA"},{"key":"2377_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nm.4500","volume":"24","author":"NM Badders","year":"2018","unstructured":"Badders NM, Korff A, Miranda HC, Vuppala PK, Smith RB, Winborn BJ, Quemin ER, Sopher BL, Dearman J, Messing J et al (2018) Selective modulation of the androgen receptor AF2 domain rescues degeneration in spinal bulbar muscular atrophy. Nat Med 24:427\u2013437. https:\/\/doi.org\/10.1038\/nm.4500","journal-title":"Nat Med"},{"key":"2377_CR19","doi-asserted-by":"publisher","first-page":"e176383","DOI":"10.1172\/jci.insight.176383","volume":"9","author":"AT Tebbenkamp","year":"2024","unstructured":"Tebbenkamp AT, Huggett SB, Lombardi V, Zampedri L, AlQahtani A, Kokkinis A, Malaspina A, Rinaldi C, Grunseich C, Fratta P et al (2024) Protein biomarker signature in patients with spinal and bulbar muscular atrophy. JCI Insight 9:e176383. https:\/\/doi.org\/10.1172\/jci.insight.176383","journal-title":"JCI Insight"},{"key":"2377_CR20","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/acn3.52087","volume":"11","author":"W Ju","year":"2024","unstructured":"Ju W, Ban JJ, Im HR, Ko SH, Seo J, Min YG, Hong YH, Choi SJ, Sung JJ (2024) Association of serum Spp1 levels with disease progression in ALS and SBMA. Ann Clin Transl Neurol 11:1809\u20131818. https:\/\/doi.org\/10.1002\/acn3.52087","journal-title":"Ann Clin Transl Neurol"},{"key":"2377_CR21","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/wnl.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34:939\u2013944. https:\/\/doi.org\/10.1212\/wnl.34.7.939","journal-title":"Neurology"},{"key":"2377_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","volume":"256","author":"RC Petersen","year":"2004","unstructured":"Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. J Intern Med 256:183\u2013194. https:\/\/doi.org\/10.1111\/j.1365-2796.2004.01388.x","journal-title":"J Intern Med"},{"key":"2377_CR23","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S1474-4422(11)70077-1","volume":"10","author":"H Barthel","year":"2011","unstructured":"Barthel H, Gertz HJ, Dresel S, Peters O, Bartenstein P, Buerger K, Hiemeyer F, Wittemer-Rump SM, Seibyl J, Reininger C et al (2011) Cerebral amyloid-beta PET with florbetaben (18F) in patients with Alzheimer\u2019s disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol 10:424\u2013435. https:\/\/doi.org\/10.1016\/S1474-4422(11)70077-1","journal-title":"Lancet Neurol"},{"key":"2377_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181\u2013184. https:\/\/doi.org\/10.1136\/jnnp.55.3.181","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2377_CR25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/352077a0","volume":"352","author":"AR La Spada","year":"1991","unstructured":"La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77\u201379. https:\/\/doi.org\/10.1038\/352077a0","journal-title":"Nature"},{"key":"2377_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks BR, Miller RG, Swash M, Munsat TL, Gr WFNR (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Sc 1:293\u2013299. https:\/\/doi.org\/10.1080\/146608200300079536","journal-title":"Amyotroph Lateral Sc"},{"key":"2377_CR27","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26:1367\u20131372. https:\/\/doi.org\/10.1038\/nbt.1511","journal-title":"Nat Biotechnol"},{"key":"2377_CR28","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/nprot.2016.136","volume":"11","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Cox J (2016) The MaxQuant computational platform for mass spectrometry-based shotgun proteomics. Nat Protoc 11:2301\u20132319. https:\/\/doi.org\/10.1038\/nprot.2016.136","journal-title":"Nat Protoc"},{"key":"2377_CR29","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M (2014) Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics 13:2513\u20132526. https:\/\/doi.org\/10.1074\/mcp.M113.031591","journal-title":"Mol Cell Proteomics"},{"issue":"Suppl 16","key":"2377_CR30","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/1471-2105-13-S16-S5","volume":"13","author":"YV Karpievitch","year":"2012","unstructured":"Karpievitch YV, Dabney AR, Smith RD (2012) Normalization and missing value imputation for label-free LC\u2013MS analysis. BMC Bioinform 13(Suppl 16):S5. https:\/\/doi.org\/10.1186\/1471-2105-13-S16-S5","journal-title":"BMC Bioinform"},{"key":"2377_CR31","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1038\/s41598-021-81279-4","volume":"11","author":"L Jin","year":"2021","unstructured":"Jin L, Bi Y, Hu C, Qu J, Shen S, Wang X, Tian Y (2021) A comparative study of evaluating missing value imputation methods in label-free proteomics. Sci Rep 11:1760. https:\/\/doi.org\/10.1038\/s41598-021-81279-4","journal-title":"Sci Rep"},{"key":"2377_CR32","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1038\/s41591-025-03833-1","volume":"31","author":"M Ali","year":"2025","unstructured":"Ali M, Erabadda B, Chen Y, Xu Y, Gong K, Liu M, Pichet Binette A, Timsina J, Western D, Yang C et al (2025) Shared and disease-specific pathways in frontotemporal dementia and Alzheimer\u2019s and Parkinson\u2019s diseases. Nat Med 31:2567\u20132577. https:\/\/doi.org\/10.1038\/s41591-025-03833-1","journal-title":"Nat Med"},{"key":"2377_CR33","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1038\/s41591-025-03831-3","volume":"31","author":"A Farinas","year":"2025","unstructured":"Farinas A, Rutledge J, Bot VA, Western D, Ying K, Lawrence KA, Oh HS, Yoon S, Ding DY, Tsai AP et al (2025) Disruption of the cerebrospinal fluid-plasma protein balance in cognitive impairment and aging. Nat Med 31:2578\u20132589. https:\/\/doi.org\/10.1038\/s41591-025-03831-3","journal-title":"Nat Med"},{"key":"2377_CR34","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41586-023-06563-x","volume":"622","author":"GH Eldjarn","year":"2023","unstructured":"Eldjarn GH, Ferkingstad E, Lund SH, Helgason H, Magnusson OT, Gunnarsdottir K, Olafsdottir TA, Halldorsson BV, Olason PI, Zink F et al (2023) Large-scale plasma proteomics comparisons through genetics and disease associations. Nature 622:348\u2013358. https:\/\/doi.org\/10.1038\/s41586-023-06563-x","journal-title":"Nature"},{"key":"2377_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/978-3-319-71779-1_5","volume":"1049","author":"CJ Cortes","year":"2018","unstructured":"Cortes CJ, La Spada AR (2018) X-linked spinal and bulbar muscular atrophy: from clinical genetic features and molecular pathology to mechanisms underlying disease toxicity. Adv Exp Med Biol 1049:103\u2013133. https:\/\/doi.org\/10.1007\/978-3-319-71779-1_5","journal-title":"Adv Exp Med Biol"},{"key":"2377_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/14728222.2025.2464173","volume":"29","author":"A Sangotra","year":"2025","unstructured":"Sangotra A, Lieberman AP (2025) Therapeutic targeting of the polyglutamine androgen receptor in spinal and bulbar muscular atrophy. Expert Opin Ther Targets 29:29\u201341. https:\/\/doi.org\/10.1080\/14728222.2025.2464173","journal-title":"Expert Opin Ther Targets"},{"key":"2377_CR37","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1172\/JCI28773","volume":"116","author":"Z Yu","year":"2006","unstructured":"Yu Z, Dadgar N, Albertelli M, Gruis K, Jordan C, Robins DM, Lieberman AP (2006) Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J Clin Invest 116:2663\u20132672. https:\/\/doi.org\/10.1172\/JCI28773","journal-title":"J Clin Invest"},{"key":"2377_CR38","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.neuron.2014.03.001","volume":"82","author":"CJ Cortes","year":"2014","unstructured":"Cortes CJ, Ling SC, Guo LT, Hung G, Tsunemi T, Ly L, Tokunaga S, Lopez E, Sopher BL, Bennett CF et al (2014) Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron 82:295\u2013307. https:\/\/doi.org\/10.1016\/j.neuron.2014.03.001","journal-title":"Neuron"},{"key":"2377_CR39","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.celrep.2014.02.008","volume":"7","author":"AP Lieberman","year":"2014","unstructured":"Lieberman AP, Yu Z, Murray S, Peralta R, Low A, Guo S, Yu XX, Cortes CJ, Bennett CF, Monia BP et al (2014) Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy. Cell Rep 7:774\u2013784. https:\/\/doi.org\/10.1016\/j.celrep.2014.02.008","journal-title":"Cell Rep"},{"key":"2377_CR40","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1093\/rheumatology\/keac415","volume":"62","author":"IA Szilagyi","year":"2023","unstructured":"Szilagyi IA, Vallerga CL, Boer CG, Schiphof D, Ikram MA, Bierma-Zeinstra SMA, van Meurs JBJ (2023) Plasma proteomics identifies CRTAC1 as a biomarker for osteoarthritis severity and progression. Rheumatology 62:1286\u20131295. https:\/\/doi.org\/10.1093\/rheumatology\/keac415","journal-title":"Rheumatology"},{"key":"2377_CR41","doi-asserted-by":"publisher","first-page":"6486","DOI":"10.1002\/alz.14142","volume":"20","author":"MR Duggan","year":"2024","unstructured":"Duggan MR, Yang Z, Cui Y, Dark HE, Wen J, Erus G, Hohman TJ, Chen J, Lewis A, Moghekar A et al (2024) Proteomic analyses reveal plasma EFEMP1 and CXCL12 as biomarkers and determinants of neurodegeneration. Alzheimers Dement 20:6486\u20136505. https:\/\/doi.org\/10.1002\/alz.14142","journal-title":"Alzheimers Dement"},{"issue":"14","key":"2377_CR42","doi-asserted-by":"publisher","first-page":"14528","DOI":"10.18632\/aging.103497","volume":"12","author":"W Xu","year":"2020","unstructured":"Xu W, Su BJ, Shen XN, Bi YL, Tan CC, Li JQ, Cao XP, Dong Q, Tan L, Yu JT, Alzheimer\u2019s Disease Neuroimaging Initiative (2020) Plasma sex hormone-binding globulin predicts neurodegeneration and clinical progression in prodromal Alzheimer\u2019s disease. Aging 12(14):14528","journal-title":"Aging"},{"key":"2377_CR43","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2174\/1567205013666151218145752","volume":"13","author":"J Xu","year":"2016","unstructured":"Xu J, Xia LL, Song N, Chen SD, Wang G (2016) Testosterone, estradiol, and sex hormone-binding globulin in Alzheimer\u2019s disease: a meta-analysis. Curr Alzheimer Res 13:215\u2013222. https:\/\/doi.org\/10.2174\/1567205013666151218145752","journal-title":"Curr Alzheimer Res"},{"key":"2377_CR44","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/156720511794604570","volume":"8","author":"TA Viel","year":"2011","unstructured":"Viel TA, Buck HS (2011) Kallikrein-kinin system mediated inflammation in Alzheimer\u2019s disease in vivo. Curr Alzheimer Res 8:59\u201366. https:\/\/doi.org\/10.2174\/156720511794604570","journal-title":"Curr Alzheimer Res"},{"key":"2377_CR45","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1073\/pnas.1810020116","volume":"116","author":"K Gobel","year":"2019","unstructured":"Gobel K, Asaridou CM, Merker M, Eichler S, Herrmann AM, Geuss E, Ruck T, Schungel L, Groeneweg L, Narayanan V et al (2019) Plasma kallikrein modulates immune cell trafficking during neuroinflammation via PAR2 and bradykinin release. Proc Natl Acad Sci USA 116:271\u2013276. https:\/\/doi.org\/10.1073\/pnas.1810020116","journal-title":"Proc Natl Acad Sci USA"},{"key":"2377_CR46","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.ajpath.2013.01.021","volume":"182","author":"GF Passos","year":"2013","unstructured":"Passos GF, Medeiros R, Cheng D, Vasilevko V, Laferla FM, Cribbs DH (2013) The bradykinin B1 receptor regulates Abeta deposition and neuroinflammation in Tg-SwDI mice. Am J Pathol 182:1740\u20131749. https:\/\/doi.org\/10.1016\/j.ajpath.2013.01.021","journal-title":"Am J Pathol"},{"key":"2377_CR47","doi-asserted-by":"publisher","first-page":"567678","DOI":"10.3389\/fphys.2020.567678","volume":"11","author":"MS Uddin","year":"2020","unstructured":"Uddin MS, Rahman MM, Sufian MA, Jeandet P, Ashraf GM, Bin-Jumah MN, Mousa SA, Abdel-Daim MM, Akhtar MF, Saleem A et al (2020) Exploring the new horizon of AdipoQ in obesity-related Alzheimer\u2019s dementia. Front Physiol 11:567678. https:\/\/doi.org\/10.3389\/fphys.2020.567678","journal-title":"Front Physiol"},{"key":"2377_CR48","doi-asserted-by":"publisher","first-page":"e13493","DOI":"10.1111\/jne.13493","volume":"37","author":"L Sindzingre","year":"2025","unstructured":"Sindzingre L, Bouaziz-Amar E, Mouton-Liger F, Cognat E, Dumurgier J, Gotze K, Martinet M, Vrillon A, Paquet C, Lilamand M (2025) Plasma adiponectin and biomarker-confirmed Alzheimer\u2019s disease in a tertiary memory clinic. J Neuroendocrinol 37:e13493. https:\/\/doi.org\/10.1111\/jne.13493","journal-title":"J Neuroendocrinol"},{"key":"2377_CR49","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1111\/j.1468-1331.2010.03194.x","volume":"18","author":"K Une","year":"2011","unstructured":"Une K, Takei YA, Tomita N, Asamura T, Ohrui T, Furukawa K, Arai H (2011) Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer\u2019s disease. Eur J Neurol 18:1006\u20131009. https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03194.x","journal-title":"Eur J Neurol"},{"key":"2377_CR50","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3390\/ijms21041219","volume":"21","author":"HM Choi","year":"2020","unstructured":"Choi HM, Doss HM, Kim KS (2020) Multifaceted physiological roles of adiponectin in inflammation and diseases. Int J Mol Sci 21:1219. https:\/\/doi.org\/10.3390\/ijms21041219","journal-title":"Int J Mol Sci"},{"key":"2377_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.coph.2021.06.012","volume":"60","author":"P Baloni","year":"2021","unstructured":"Baloni P, Funk CC, Readhead B, Price ND (2021) Systems modeling of metabolic dysregulation in neurodegenerative diseases. Curr Opin Pharmacol 60:59\u201365. https:\/\/doi.org\/10.1016\/j.coph.2021.06.012","journal-title":"Curr Opin Pharmacol"},{"key":"2377_CR52","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H (2023) Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther 8:267. https:\/\/doi.org\/10.1038\/s41392-023-01486-5","journal-title":"Signal Transduct Target Ther"},{"key":"2377_CR53","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.tins.2023.03.007","volume":"46","author":"CM Alberini","year":"2023","unstructured":"Alberini CM (2023) IGF2 in memory, neurodevelopmental disorders, and neurodegenerative diseases. Trends Neurosci 46:488\u2013502. https:\/\/doi.org\/10.1016\/j.tins.2023.03.007","journal-title":"Trends Neurosci"},{"key":"2377_CR54","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41420-023-01734-1","volume":"9","author":"J Arcos","year":"2023","unstructured":"Arcos J, Grunenwald F, Sepulveda D, Jerez C, Urbina V, Huerta T, Troncoso-Escudero P, Tirado D, Perez A, Diaz-Espinoza R et al (2023) IGF2 prevents dopaminergic neuronal loss and decreases intracellular alpha-synuclein accumulation in Parkinson\u2019s disease models. Cell Death Discov 9:438. https:\/\/doi.org\/10.1038\/s41420-023-01734-1","journal-title":"Cell Death Discov"},{"key":"2377_CR55","doi-asserted-by":"publisher","first-page":"102095","DOI":"10.1016\/j.redox.2021.102095","volume":"46","author":"E Martin-Montanez","year":"2021","unstructured":"Martin-Montanez E, Valverde N, Ladron de Guevara-Miranda D, Lara E, Romero-Zerbo YS, Millon C, Boraldi F, Avila-Gamiz F, Perez-Cano AM, Garrido-Gil P et al (2021) Insulin-like growth factor II prevents oxidative and neuronal damage in cellular and mice models of Parkinson\u2019s disease. Redox Biol 46:102095. https:\/\/doi.org\/10.1016\/j.redox.2021.102095","journal-title":"Redox Biol"},{"key":"2377_CR56","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.4103\/1673-5374.355815","volume":"18","author":"HY Zhang","year":"2023","unstructured":"Zhang HY, Jiang YC, Li JR, Yan JN, Wang XJ, Shen JB, Ke KF, Gu XS (2023) Neuroprotective effects of insulin-like growth factor-2 in 6-hydroxydopamine-induced cellular and mouse models of Parkinson\u2019s disease. Neural Regen Res 18:1099\u20131106. https:\/\/doi.org\/10.4103\/1673-5374.355815","journal-title":"Neural Regen Res"},{"key":"2377_CR57","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","volume":"8","author":"SY Pang","year":"2019","unstructured":"Pang SY, Ho PW, Liu HF, Leung CT, Li L, Chang EES, Ramsden DB, Ho SL (2019) The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson\u2019s disease. Transl Neurodegener 8:23. https:\/\/doi.org\/10.1186\/s40035-019-0165-9","journal-title":"Transl Neurodegener"},{"key":"2377_CR58","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/acn3.50854","volume":"6","author":"ER McGrath","year":"2019","unstructured":"McGrath ER, Himali JJ, Levy D, Conner SC, DeCarli CS, Pase MP, Courchesne P, Satizabal CL, Vasan RS, Beiser AS et al (2019) Circulating IGFBP-2: a novel biomarker for incident dementia. Ann Clin Transl Neurol 6:1659\u20131670. https:\/\/doi.org\/10.1002\/acn3.50854","journal-title":"Ann Clin Transl Neurol"},{"key":"2377_CR59","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fnins.2018.00476","volume":"12","author":"LW Bonham","year":"2018","unstructured":"Bonham LW, Geier EG, Steele NZR, Holland D, Miller BL, Dale AM, Desikan RS, Yokoyama JS, Alzheimer\u2019s Disease Neuroimaging I (2018) Insulin-like growth factor binding protein 2 is associated with biomarkers of Alzheimer\u2019s disease pathology and shows differential expression in transgenic mice. Front Neurosci 12:476. https:\/\/doi.org\/10.3389\/fnins.2018.00476","journal-title":"Front Neurosci"},{"key":"2377_CR60","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.3390\/ijms18102128","volume":"18","author":"C De Luca","year":"2017","unstructured":"De Luca C, Virtuoso A, Maggio N, Papa M (2017) Neuro-coagulopathy: blood coagulation factors in central nervous system diseases. Int J Mol Sci 18:2128. https:\/\/doi.org\/10.3390\/ijms18102128","journal-title":"Int J Mol Sci"},{"key":"2377_CR61","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s41418-020-00664-0","volume":"28","author":"JH Hor","year":"2021","unstructured":"Hor JH, Santosa MM, Lim VJW, Ho BX, Taylor A, Khong ZJ, Ravits J, Fan Y, Liou YC, Soh BS et al (2021) ALS motor neurons exhibit hallmark metabolic defects that are rescued by SIRT3 activation. Cell Death Differ 28:1379\u20131397. https:\/\/doi.org\/10.1038\/s41418-020-00664-0","journal-title":"Cell Death Differ"},{"key":"2377_CR62","doi-asserted-by":"publisher","first-page":"783624","DOI":"10.3389\/fnins.2021.783624","volume":"15","author":"BC Benson","year":"2021","unstructured":"Benson BC, Shaw PJ, Azzouz M, Highley JR, Hautbergue GM (2021) Proteinopathies as hallmarks of impaired gene expression, proteostasis and mitochondrial function in amyotrophic lateral sclerosis. Front Neurosci 15:783624. https:\/\/doi.org\/10.3389\/fnins.2021.783624","journal-title":"Front Neurosci"},{"key":"2377_CR63","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.3390\/cells9041065","volume":"9","author":"M Kodavati","year":"2020","unstructured":"Kodavati M, Wang H, Hegde ML (2020) Altered mitochondrial dynamics in motor neuron disease: an emerging perspective. Cells-Basel 9:1065. https:\/\/doi.org\/10.3390\/cells9041065","journal-title":"Cells-Basel"},{"key":"2377_CR64","doi-asserted-by":"publisher","first-page":"10401","DOI":"10.3389\/ebm.2024.10401","volume":"249","author":"S Koks","year":"2024","unstructured":"Koks S, Rallmann K, Muldmaa M, Price J, Pfaff AL, Taba P (2024) Whole blood transcriptome profile identifies motor neurone disease RNA biomarker signatures. Exp Biol Med 249:10401. https:\/\/doi.org\/10.3389\/ebm.2024.10401","journal-title":"Exp Biol Med"},{"key":"2377_CR65","doi-asserted-by":"publisher","first-page":"5673","DOI":"10.3390\/ijms22115673","volume":"22","author":"C Malacarne","year":"2021","unstructured":"Malacarne C, Galbiati M, Giagnorio E, Cavalcante P, Salerno F, Andreetta F, Cagnoli C, Taiana M, Nizzardo M, Corti S et al (2021) Dysregulation of muscle-specific MicroRNAs as common pathogenic feature associated with muscle atrophy in ALS, SMA and SBMA: evidence from animal models and human patients. Int J Mol Sci 22:5673. https:\/\/doi.org\/10.3390\/ijms22115673","journal-title":"Int J Mol Sci"},{"key":"2377_CR66","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1002\/ana.70025","volume":"98","author":"C Steffke","year":"2025","unstructured":"Steffke C, Baskar K, Bachhuber F, Wiesenfarth M, Dorst J, Schuster J, Sch\u00f6berl F, Reilich P, Regensburger M, German A et al (2025) Targeted proteomics upon treatment with tofersen identifies novel response markers for superoxide dismutase 1-linked amyotrophic lateral sclerosis. Ann Neurol 98:1318\u20131334. https:\/\/doi.org\/10.1002\/ana.70025","journal-title":"Ann Neurol"},{"key":"2377_CR67","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/acn3.70001","volume":"12","author":"EV Thomas","year":"2025","unstructured":"Thomas EV, Han CE, Kim WJ, Asress S, Li YJ, Taylor JA, Gearing M, Fournier CN, Mceachin ZT, Seyfried NT et al (2025) ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progression. Ann Clin Transl Neur 12:714\u2013723. https:\/\/doi.org\/10.1002\/acn3.70001","journal-title":"Ann Clin Transl Neur"},{"key":"2377_CR68","doi-asserted-by":"publisher","first-page":"100498","DOI":"10.1016\/j.xhgg.2025.100498","volume":"7","author":"J Dulski","year":"2026","unstructured":"Dulski J, Boddapati AK, Risi B, Iruzubieta P, Orlacchio A, Fernandez-Torron R, Castillo-Trivino T, Munain ALD, Vucic S, Padovani A et al (2026) Targeted plasma proteomics uncover proteins associated with-linked SPG10 and ALS spectrum disorders. Hum Genet Genom Adv 7:100498. https:\/\/doi.org\/10.1016\/j.xhgg.2025.100498","journal-title":"Hum Genet Genom Adv"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-026-02377-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02377-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-026-02377-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:01:27Z","timestamp":1791313287000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-026-02377-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2377"],"URL":"https:\/\/doi.org\/10.1186\/s40478-026-02377-w","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"6 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All participants underwent clinical evaluation at the Neurodegenerative Disease Center of Kyungpook National University Chilgok Hospital (KNUCH) during the period from 2020 to 2023. Written informed consent was obtained from each participant and, where applicable, from their legally authorized caregivers prior to enrollment. The study protocol was reviewed and approved by the Institutional Review Board of KNUCH (approval number: KNUMC-2023-01-036-001).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflict of interest that might potentially bias this work.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"203"}}